ConvaTec Group PLC
LSE:CTEC
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.2B GBP |
Loading...
|
|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
65.7B USD |
Loading...
|
|
| JP |
|
Hoya Corp
TSE:7741
|
9.8T JPY |
Loading...
|
|
| CH |
|
Alcon AG
SIX:ALC
|
32B CHF |
Loading...
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
108.9B DKK |
Loading...
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.5B USD |
Loading...
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6.6B USD |
Loading...
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
41.1B CNY |
Loading...
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
865B JPY |
Loading...
|
|
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5B USD |
Loading...
|
|
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
4.7B USD |
Loading...
|
Market Distribution
| Min | -1 510% |
| 30th Percentile | 0.4% |
| Median | 0.5% |
| 70th Percentile | 0.7% |
| Max | 7 323.1% |
Other Profitability Ratios
ConvaTec Group PLC
Glance View
ConvaTec Group PLC is a notable player in the realm of medical products and technologies, deftly weaving its narrative within the healthcare industry. Founded in 1978, the company has steadily established itself through strategic expansion and innovation, focusing on improving the lives of patients and enhancing healthcare delivery. The company's core business revolves around four main product categories: Advanced Wound Care, Ostomy Care, Continence and Critical Care, and Infusion Care. Each of these sectors is backed by a robust commitment to research and development, allowing ConvaTec to deliver specialized products that cater to both specific patient needs and broader healthcare system demands. ConvaTec's financial model centers around providing essential, high-quality medical solutions that ultimately support improved patient outcomes. The company garners revenue by partnering with hospitals, healthcare providers, and direct consumer channels, ensuring its products reach where they are most needed. With a global footprint spanning multiple continents, ConvaTec not only distributes its products widely but also adapts its strategy to meet the nuanced requirements of diverse markets. By aligning itself closely with caregivers and leveraging cutting-edge technology, the company maintains a sustainable economic engine through both recurring sales from consumables and long-term relationships with its institutional clients.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for ConvaTec Group PLC is 55.9%, which is below its 3-year median of 56.1%.
Over the last 3 years, ConvaTec Group PLC’s Gross Margin has increased from 54.1% to 55.9%. During this period, it reached a low of 54.1% on Jun 30, 2022 and a high of 57.1% on Dec 31, 2023.